ライフサイエンスコーパス: generalized anxiety disorder

1 from 50.0% (alcohol use disorder) to 89.2% (generalized anxiety disorder).

2 disorder, major depressive disorder, and/or generalized anxiety disorder).

3 nstructed emotion regulation is perturbed in generalized anxiety disorder.

4 cipatory processes in the pathophysiology of generalized anxiety disorder.

5 outcomes, or worry, is a cardinal symptom of generalized anxiety disorder.

6 ncluding major depressive disorder (MDD) and generalized anxiety disorder.

7 ed to self-reported anxiety in patients with generalized anxiety disorder.

8 expressions in generalized social phobia and generalized anxiety disorder.

9 ients with generalized social phobia without generalized anxiety disorder.

10 ions differ in generalized social phobia and generalized anxiety disorder.

11 tolerated short-term treatment for pediatric generalized anxiety disorder.

12 se venlafaxine in the treatment of pediatric generalized anxiety disorder.

13 ) at age 45 years for depressive episode and generalized anxiety disorder.

14 een healthy adolescents and adolescents with generalized anxiety disorder.

15 efficacious and well-tolerated treatment for generalized anxiety disorder.

16 s studied for the treatment of patients with generalized anxiety disorder.

17 ixed doses of paroxetine in the treatment of generalized anxiety disorder.

18 eliminated for all anxiety disorders except generalized anxiety disorder.

19 nd 3) those with neither DSM-IV nor modified generalized anxiety disorder.

20 tive, rapidly acting, and safe treatment for generalized anxiety disorder.

21 tional impairments during decision making in generalized anxiety disorder.

22 disorder, posttraumatic stress disorder, and generalized anxiety disorder.

23 ties of 0.43 for panic disorder and 0.32 for generalized anxiety disorder.

24 and expected reinforcement) is disrupted in generalized anxiety disorder.

25 thymia, social phobia, major depression, and generalized anxiety disorder.

26 nts with major depression with and without a generalized anxiety disorder.

27 -based decision making have been reported in generalized anxiety disorder.

28 therapeutic effects on major depression and generalized anxiety disorder.

29 episode, phobias, alcohol use disorders, and generalized anxiety disorder.

30 and function have focused on depression and generalized anxiety disorder.

31 was major depressive disorder with comorbid generalized anxiety disorder.

32 se and prevents relapse in older adults with generalized anxiety disorder.

33 to predict new onset of specific phobia and generalized anxiety disorder.

34 nts with social phobia, and adolescents with generalized anxiety disorder.

35 e hypothesis that it predicts depressive and generalized anxiety disorders.

36 mptoms in post-traumatic stress disorder and generalized anxiety disorders.

37 it hyperactivity disorder (1.82, 1.76-1.88), generalized anxiety disorder (1.79, 1.74-1.85), bipolar

38 ic illness: major depressive disorder (27%), generalized anxiety disorder (10%), panic disorder (10%)

39 depressive disorder] and 43 (5.3%) for GAD [generalized anxiety disorder] (11 [1.4%] had comorbidity

40 ous trait for anxiety (based on score on the Generalized Anxiety Disorder 2-item scale [GAD-2], N=199

41 mental health (major depressive episode and generalized anxiety disorder), (2) substance use (smokin

42 ve disorder: 1) those with coexisting DSM-IV generalized anxiety disorder, 2) those with coexisting m

43 ness symptoms were assessed using the 2-item Generalized Anxiety Disorder, 2-item Patient Health Ques

44 h Questionnaire-2 for depression, a two-item Generalized Anxiety Disorder-2 questionnaire for anxiety

45 ith the Patient Health Questionnaire and the Generalized Anxiety Disorder-2 Scale, respectively.

46 ; 95% confidence interval [CI], 1.53-30.17), generalized anxiety disorder (20.5% vs 3.71%; OR, 5.53;

47 major depression (32 versus 7%, P < 0.0001), generalized anxiety disorder (21 versus 2%, P < 0.005),

48 sorder (7.3%), alcohol use disorders (5.2%), generalized anxiety disorder (3.7%), and panic disorder

49 s disorder, 4.0% (95% CI, 1.7% to 7.7%), and generalized anxiety disorder, 3.5% (95% CI, 1.4% to 7.1%

50 ring neuroses were depressive episode (37%), generalized anxiety disorder (31%), agoraphobia or panic

51 12.6%), panic disorder (24.8% versus 4.0%), generalized anxiety disorder (38.6% versus 8.4%), and al

52 Patterns of comorbidity for panic (51%), generalized anxiety disorder (55%), and major depression

53 ress disorder, 7.6% (CI, 5.9% to 9.4%) had a generalized anxiety disorder, 6.8% (CI, 5.3% to 8.6%) ha

54 ety symptoms (Hopkins symptom check list-25, Generalized anxiety disorder 7 questionnaire, and Beck's

55 estionnaire 9-item depression scale, and the Generalized Anxiety Disorder 7-item scale.

56 cale or Patient Health Questionnaire 9-Item, Generalized Anxiety Disorder 7-Item, Posttraumatic Stres

57 and 14.7%, respectively; suicidality, 20.2%; generalized anxiety disorder, 7.9%; posttraumatic stress

58 and depression, with anxiety measured by the Generalized Anxiety Disorder-7 and depression measured b

59 ire-9 item (PHQ-9) score of 10 or greater, a Generalized Anxiety Disorder-7 item (GAD-7) score of 10

60 essive symptoms were characterized using the Generalized Anxiety Disorder-7 questionnaire and Patient

61 Evaluation Questionnaire-Mizan (LSEQ-M), the Generalized Anxiety Disorder-7 Scale (GAD-7), and the Sl

62 CI, -4.4 to 0 points; P = .05), and anxiety (Generalized Anxiety Disorder-7 score: -3.1 points vs -0.

63 12 months post-injury to screen for anxiety (generalized anxiety disorder-7), depression (patient hea

64 stionnaire-8; and r=-0.540, P<0.001 with the Generalized Anxiety Disorder-7).

65 easures applied in primary care, such as the Generalized Anxiety Disorder-7, can aid in diagnosis of

66 Panic attacks occurred in five patients with generalized anxiety disorder (71%) and in one normal sub

67 For generalized anxiety disorder, a pooled analysis of 3 tri

68 e 5-17 years who met the DSM-IV criteria for generalized anxiety disorder according to the Anxiety Di

69 ltiple neuropsychiatric disorders, including generalized anxiety disorders, addiction, schizophrenia,

70 7, for selected 12-month anxiety disorders (generalized anxiety disorder, agoraphobia, and social ph

71 phrenia, bipolar disorder, major depression, generalized anxiety disorder, agoraphobia, social phobia

72 ce associations with most mood disorders and generalized anxiety disorder also remained significant.

73 Patients with generalized anxiety disorder also showed greater attenti

74 pressed patients with and without a comorbid generalized anxiety disorder, although time to recovery

75 mary trials of interest, 18 adolescents with generalized anxiety disorder and 15 comparison subjects

76 Seventeen patients with generalized anxiety disorder and 24 healthy comparison s

77 " To test this, we recruited 32 females with generalized anxiety disorder and 25 age-matched healthy

78 THOD: Forty-six unmedicated individuals with generalized anxiety disorder and 32 healthy comparison s

79 Forty-six unmedicated individuals with generalized anxiety disorder and 32 healthy comparison s

80 c neuralgia, diabetic peripheral neuropathy, generalized anxiety disorder and adjunctive therapy for

81 loading most heavily on major depression and generalized anxiety disorder and another loading most st

82 10, to 24 individuals (3 male subjects) with generalized anxiety disorder and assessed its effects on

83 reat cues differentially in adolescents with generalized anxiety disorder and in healthy adolescents.

84 suggest an association between treatment for generalized anxiety disorder and lower risk of depressio

85 Development in the United States Survey for generalized anxiety disorder and major depression at 12

86 pression only, and 25 patients with comorbid generalized anxiety disorder and major depression were s

87 used to obtain diagnostic classifications of generalized anxiety disorder and major depressive disord

88 the DSM-IV hierarchical relationship between generalized anxiety disorder and mood disorders, the aut

89 e used to decompose the correlations between generalized anxiety disorder and neuroticism into geneti

90 l-specific environmental correlation between generalized anxiety disorder and neuroticism was estimat

91 Lifetime generalized anxiety disorder and neuroticism were assess

92 emoved from the models, correlations between generalized anxiety disorder and neuroticism were estima

93 Genetic correlations between generalized anxiety disorder and neuroticism were high a

94 Outpatients (N=566) with generalized anxiety disorder and no other axis I disorde

95 and placebo were evaluated in patients with generalized anxiety disorder and normal comparison subje

96 mygdala responses to anticipatory signals in generalized anxiety disorder and of anterior cingulate c

97 Major depression occurs with generalized anxiety disorder and panic disorder in up to

98 ence of internalizing disorders (depression, generalized anxiety disorder and post-traumatic stress d

99 everal neuropsychiatric disorders, including generalized anxiety disorder and posttraumatic stress di

100 ow risk vs moderate/high risk), past 6-month generalized anxiety disorder and posttraumatic stress di

101 Seven patients with generalized anxiety disorder and seven age- and sex-matc

102 pernicious effect of PersDs on the course of generalized anxiety disorder and social phobia but not p

103 onship between major depressive disorder and generalized anxiety disorder and suggest that the exclus

104 examined the sources of covariation between generalized anxiety disorder and the personality trait o

105 r or having been prescribed a medication for generalized anxiety disorder and the risk of depression.

106 tion between specific forms of treatment for generalized anxiety disorder and the risk of major depre

107 ermine the association between treatment for generalized anxiety disorder and the risk of major depre

108 treatment of psychic and somatic symptoms of generalized anxiety disorder and was well tolerated by m

109 older with a DSM-IV anxiety disorder (mainly generalized anxiety disorder) and a Hamilton Anxiety Rat

110 disorder, 2) those with coexisting modified generalized anxiety disorder, and 3) those with neither

111 ectual disability, autism spectrum disorder, generalized anxiety disorder, and a >40-fold increased r

112 schizophrenia, bipolar disorder, depression, generalized anxiety disorder, and a healthy comparison g

113 ocial phobia, posttraumatic stress disorder, generalized anxiety disorder, and obsessive-compulsive d

114 e, major depressive episode, phobias, panic, generalized anxiety disorder, and obsessive-compulsive d

115 icantly increased risk for major depression, generalized anxiety disorder, and panic disorder.

116 ent an important advance in the treatment of generalized anxiety disorder, and perhaps other anxiety

117 t disorder; the second, on major depression, generalized anxiety disorder, and phobia.

118 iety Disorders (ANX) such as panic disorder, generalized anxiety disorder, and phobias, are highly pr

119 For panic disorder, generalized anxiety disorder, and probably phobias, gene

120 associated with benefits in the treatment of generalized anxiety disorder, and risperidone was associ

121 ers, notably substance dependence, panic and generalized anxiety disorder, and several personality di

122 r antagonists for major depressive disorder, generalized anxiety disorder, and social anxiety disorde

123 adolescents for separation anxiety disorder, generalized anxiety disorder, and social phobia.

124 , individual medical conditions, depression, generalized anxiety disorder, and substance use disorder

125 s disorder (PTSD), major depressive episode, generalized anxiety disorder, and suicidality, as well a

126 tric disorders (major depression, dysthymia, generalized anxiety disorders, and panic attacks) and dr

127 Patients with generalized anxiety disorder appear to exhibit greater s

128 s well as dependence with mood disorders and generalized anxiety disorder, appears to be due in part

129 Panic disorder and generalized anxiety disorder are prevalent in primary ca

130 ctivation in this region in adolescents with generalized anxiety disorder as well as healthy adolesce

131 This is the first evidence in juveniles that generalized anxiety disorder-associated patterns of path

132 The majority of respondents with generalized anxiety disorder at 12 months in the Nationa

133 The prevalences of generalized anxiety disorder at 12 months were 3.1% and

134 ated with elevated adjusted odds of PTSD and generalized anxiety disorder at T2 and T3 and of major d

135 Adult outpatients with generalized anxiety disorder but not major depressive di

136 e adolescents-14 with social phobia, 18 with generalized anxiety disorder but not social phobia, and

137 -ANX, comorbid major depressive disorder and generalized anxiety disorder can be accurately predicted

138 tion of disorder-relevant neural circuits in generalized anxiety disorder can be beneficially altered

139 Only for panic disorder and generalized anxiety disorder could the authors identify

140 e treatment of children and adolescents with generalized anxiety disorder, depression, obsessive comp

141 ractivity disorder, hypertension, depression/generalized anxiety disorder, diabetes mellitus, gastroe

142 ere strongly related to the probability of a generalized anxiety disorder diagnosis.

143 all difference was that major depression and generalized anxiety disorder dimensions had small but si

144 truments had adequate accuracy for detecting generalized anxiety disorder (eg, across 3 studies the G

145 essive disorder who met all the criteria for generalized anxiety disorder except for the exclusion cr

146 rs, the authors made a diagnosis of modified generalized anxiety disorder for patients with major dep

147 total of 1,614 individuals with and without generalized anxiety disorder from a psychiatric clinic a

148 on regulation deficits figure prominently in generalized anxiety disorder (GAD) and in other anxiety

149 The close association between generalized anxiety disorder (GAD) and major depressive

150 ales and females with a primary diagnosis of generalized anxiety disorder (GAD) and nonpsychiatric co

151 Past-year major depression (MD), generalized anxiety disorder (GAD) and panic disorder (P

152 ce imaging (fMRI) data from individuals with generalized anxiety disorder (GAD) and panic disorder (P

153 In primary care settings, generalized anxiety disorder (GAD) and panic disorder ar

154 Generalized social phobia (GSP) and generalized anxiety disorder (GAD) are both associated w

155 Major depressive disorder (MDD) and generalized anxiety disorder (GAD) are highly prevalent

156 Insomnia and generalized anxiety disorder (GAD) are prevalent disorde

157 Among test accuracy studies, only the Generalized Anxiety Disorder (GAD) GAD-2 and GAD-7 scree

158 To determine whether panic disorder or generalized anxiety disorder (GAD) in pregnancy, or medi

159 Generalized anxiety disorder (GAD) is a chronic disorder

160 Generalized anxiety disorder (GAD) is a common and disab

161 Generalized anxiety disorder (GAD) is a common chronic c

162 Generalized anxiety disorder (GAD) is characterized by t

163 Generalized anxiety disorder (GAD) is common in older ad

164 Generalized anxiety disorder (GAD) is one of the most co

165 Analyses for panic disorder and generalized anxiety disorder (GAD) produced comparable f

166 therapy (CBT) can be effective for late-life generalized anxiety disorder (GAD), but only pilot studi

167 Post-traumatic stress disorder (PTSD) and generalized anxiety disorder (GAD), eg, share elevated a

168 imaging study was conducted of patients with generalized anxiety disorder (GAD), major depressive dis

169 3), but not major depressive disorder (MDD), generalized anxiety disorder (GAD), or any SUD.

170 tients with cardiac disease with depression, generalized anxiety disorder (GAD), or panic disorder; u

171 bed in posttraumatic stress disorder (PTSD), generalized anxiety disorder (GAD), panic disorder (PD),

172 itioning studies assessing generalization in generalized anxiety disorder (GAD), results of this meta

173 mple of adolescents (age 12-17, N = 41) with generalized anxiety disorder (GAD), who participated in

174 wn about the neural abnormalities underlying generalized anxiety disorder (GAD).

175 Vigilance for threat is a key feature of generalized anxiety disorder (GAD).

176 1522, age 32-72 years) were administered the Generalized Anxiety Disorder (GAD-7) instrument, whole b

177 We tested patients with generalized anxiety disorder (GAD; n = 32, female) and h

178 g treatment for anxiety (defined as a 7-item Generalized Anxiety Disorder [GAD-7] score of >=10) and/

179 of life subscale), level of anxiety (7-item Generalized Anxiety Disorder; GAD-7), level of depressio

180 The generalized anxiety disorder group showed a unique valen

181 The two generalized anxiety disorder groups did not differ from

182 than that seen in the healthy comparison and generalized anxiety disorder groups.

183 depressed patients with DSM-IV and modified generalized anxiety disorder had higher levels of suicid

184 This study tested whether patients with generalized anxiety disorder have alterations in anticip

185 Few neuroimaging studies of generalized anxiety disorder have been conducted.

186 Current drug therapies for generalized anxiety disorder have limitations.

187 ared with psychological or pill placebo (eg, generalized anxiety disorder: Hedges g = 1.01 [large eff

188 e experiences that increase vulnerability to generalized anxiety disorder, however, have only modest

189 of symptoms that met inclusion criteria for generalized anxiety disorder in a depressive episode.

190 of OCD, social phobia, specific phobia, and generalized anxiety disorder in childhood, before they d

191 is safe and efficacious for the treatment of generalized anxiety disorder in children and adolescents

192 e inhibitor, and placebo in the treatment of generalized anxiety disorder in children and adolescents

193 ological worry; and a higher morbid risk for generalized anxiety disorder in first-degree family memb

194 trates effective strategies for treatment of generalized anxiety disorder in older adults.

195 rated option for the short-term treatment of generalized anxiety disorder in outpatients without majo

196 , specifically of social situations, whereas generalized anxiety disorder involves intrusive worry ab

197 ticism and those that increase liability for generalized anxiety disorder, irrespective of gender.

198 cataplexy, dysthymic disorder, fibromyalgia, generalized anxiety disorder, irritable bowel syndrome,

199 Generalized anxiety disorder is associated with asymmetr

200 Generalized anxiety disorder is associated with hyperact

201 Generalized anxiety disorder is common among older adult

202 r depression and that the role impairment of generalized anxiety disorder is comparable to that of ma

203 t or whether the impairment of patients with generalized anxiety disorder is due to depression or oth

204 ed collaborative care for panic disorder and generalized anxiety disorder is more effective than usua

205 gregation; the role of family environment in generalized anxiety disorder is uncertain.

206 The authors questioned whether generalized anxiety disorder itself is associated with r

207 ve to the comparison subjects, patients with generalized anxiety disorder manifested greater right ve

208 Symptoms that met inclusion criteria for generalized anxiety disorder, measured separately, were

209 Generalized anxiety disorder might be better conceptuali

210 udied obsessive-compulsive disorder (n = 4), generalized anxiety disorder (n = 2), attention-deficit/

211 Compared to patients with generalized anxiety disorder (n = 24) and healthy contro

212 Patients with generalized anxiety disorder (N=107) who had been long-t

213 ender with generalized social phobia without generalized anxiety disorder (N=17), generalized anxiety

214 without generalized anxiety disorder (N=17), generalized anxiety disorder (N=17), or no psychopatholo

215 re individuals at least 60 years of age with generalized anxiety disorder (N=73) who were recruited f

216 panic disorder with or without agoraphobia, generalized anxiety disorder, obsessive-compulsive disor

217 se results show that a substantial amount of generalized anxiety disorder occurs independently of maj

218 3, 95% confidence interval [CI]=1.00-1.78]), generalized anxiety disorder (odds ratio=1.72, 95% CI=1.

219 t depression plus anxiety (specifically GAD [generalized anxiety disorder]) (odds ratio, 468.53) or d

220 f neuroticism and twice the risk of lifetime generalized anxiety disorder of men, gender-specific eff

221 ealthy comparison subjects, 18 patients with generalized anxiety disorder only, 14 patients with majo

222 having seen a mental health professional for generalized anxiety disorder or having been prescribed a

223 n that lifetime DUD was also associated with generalized anxiety disorder (OR, 1.3; 95% CI, 1.06-1.49

224 ith friends: OR, 6.26 [95% CI, 3.07-12.76]), generalized anxiety disorder (OR, 5.19 [95% CI, 2.01-13.

225 , social anxiety disorder, specific phobias, generalized anxiety disorder, or separation anxiety and

226 ry diagnosis of separation anxiety disorder, generalized anxiety disorder, or social phobia to receiv

227 Generalized anxiety disorder (P = 0.003) and alcohol dep

228 Lifetime major depression, generalized anxiety disorder, panic disorder, agoraphobi

229 Lifetime diagnoses for 6 anxiety disorders (generalized anxiety disorder, panic disorder, agoraphobi

230 The first loaded most strongly in generalized anxiety disorder, panic disorder, and agorap

231 "internalizing" (major depression, phobias, generalized anxiety disorder, panic disorder, and bulimi

232 ic stress disorder, social anxiety disorder, generalized anxiety disorder, panic disorder, and specif

233 line personality disorder, major depression, generalized anxiety disorder, panic disorder, post-traum

234 esonance imaging (fMRI) was employed with 14 generalized anxiety disorder patients and 12 healthy com

235 cortex and hippocampus of 15 medication-free generalized anxiety disorder patients and 15 age- and se

236 Generalized anxiety disorder patients had a 16.5% higher

237 In addition, generalized anxiety disorder patients reporting childhoo

238 onsidered a marker of neuronal viability, in generalized anxiety disorder patients.

239 the following 7 syndromes: major depression, generalized anxiety disorder, phobia, alcohol dependence

240 m family and twin studies of panic disorder, generalized anxiety disorder, phobias, and obsessive-com

241 Panic disorder, generalized anxiety disorder, phobias, and OCD all have

242 agoraphobia, specific phobia, social phobia, generalized anxiety disorder, posttraumatic stress disor

243 jor depressive disorder, dysthymic disorder, generalized anxiety disorder, posttraumatic stress disor

244 iety, fear, and social dysfunctions, such as generalized anxiety disorder, posttraumatic stress disor

245 ted using a larger number of substances, and generalized anxiety disorder predicted having more depen

246 Drugs that are clinically effective against generalized anxiety disorder preferentially alter rodent

247 d not implicate any specific question in the generalized anxiety disorder protocol.

248 17 years of age who met DSM-IV criteria for generalized anxiety disorder received a flexible dosage

249 In addition, individuals with generalized anxiety disorder relative to healthy partici

250 ealed that during feedback, individuals with generalized anxiety disorder relative to healthy subject

251 a PersD predicted a 30% lower likelihood of generalized anxiety disorder remission, a 39% lower like

252 The best-performing test for GAD was the Generalized Anxiety Disorder Scale 7 Item (GAD-7), with

253 se of emotion regulation strategies, and the Generalized Anxiety Disorder Scale to record anxiety sym

254 l Studies Depression scale), anxiety (7-item Generalized Anxiety Disorder scale), quality of life (12

255 Patient Health Questionnaire-9 (PHQ-9), and Generalized Anxiety Disorder Scale-7 (GAD-7), respective

256 trated moderate to high accuracy for adults (Generalized Anxiety Disorder scale: sensitivity, 70% to

257 ite score for nine delineated items from the generalized anxiety disorder section of a modified versi

258 ed children (ages 8-12); 52 met criteria for generalized anxiety disorder, separation anxiety disorde

259 nds with an anxiety disorder (social phobia, generalized anxiety disorder, separation anxiety disorde

260 ants for conduct disorder, major depression, generalized anxiety disorder, separation anxiety disorde

261 mants for conduct disorder,major depression, generalized anxiety disorder, separation anxiety disorde

262 Generalized Anxiety Disorder Severity Scale, Panic Disor

263 Adolescents with generalized anxiety disorder show greater right ventrola

264 These data demonstrate that patients with generalized anxiety disorder show significant deficits i

265 Patients with generalized anxiety disorder showed greater anticipatory

266 In contrast, patients with generalized anxiety disorder showed heightened and less

267 Behaviorally, individuals with generalized anxiety disorder showed impaired reinforceme

268 ients with generalized social phobia without generalized anxiety disorder showed increased activation

269 Only participants with generalized anxiety disorder showed robust, though small

270 In contrast, patients with generalized anxiety disorder showed significantly less a

271 least 1 of the following anxiety disorders: generalized anxiety disorder, social anxiety disorder, s

272 ents who were diagnosed with panic disorder, generalized anxiety disorder, social phobia, and/or post

273 le diagnoses of separation anxiety disorder, generalized anxiety disorder, social phobia, major depre

274 ersDs) on time to remission in patients with generalized anxiety disorder, social phobia, or panic di

275 pisode and dysthymia) and anxiety disorders (generalized anxiety disorder, social phobia, panic disor

276 order, post-traumatic stress disorder and/or generalized anxiety disorder, suicidal ideation, worse q

277 epression symptoms were only associated with generalized anxiety disorder symptoms in childhood (r =

278 onal numbing, major depressive disorder, and generalized anxiety disorder symptoms) symptoms as asses

279 etic correlation with MD modestly higher for generalized anxiety disorder than panic disorder.

280 rder, specific phobia appeared the most, and generalized anxiety disorder the least, similar to induc

281 Compared to the depressed patients without generalized anxiety disorder, the depressed patients wit

282 preclinical procedures and in patients with generalized anxiety disorder, the most common of the anx

283 Absent in generalized anxiety disorder, these aberrations highligh

284 isorder, social phobia, specific phobias and generalized anxiety disorder--these responses are exagge

285 For generalized anxiety disorder, this was true for men, but

286 n, 20 (17%) for panic disorder, 20 (17%) for generalized anxiety disorder, two (2%) for alcohol abuse

287 Psychopharmacologic treatment of generalized anxiety disorder was associated with a signi

288 ression; the association with persistence of generalized anxiety disorder was nearly significant.

289 ically, a lower likelihood of remission from generalized anxiety disorder was predicted by the presen

290 Symptoms of generalized anxiety disorder were associated with a high

291 Comorbid anxiety disorders and symptoms of generalized anxiety disorder were associated with a more

292 By contrast, patients with generalized anxiety disorder were completely unable to r

293 AUD and panic disorder, specific phobia, and generalized anxiety disorder were modest (odds ratios ra

294 Patients with generalized anxiety disorder were more likely to report

295 domized language groups: Lifetime reports of generalized anxiety disorder were more prevalent in the

296 his double-blind study, patients with DSM-IV generalized anxiety disorder were randomly assigned to r

297 adults aged 18 to 64 years with panic and/or generalized anxiety disorder who were recruited from Jul

298 neralized anxiety syndrome (GAS) (defined as generalized anxiety disorder with a 2-week minimum durat

299 release (XR) venlafaxine in outpatients with generalized anxiety disorder without concomitant major d

300 cessing contribute to the pathophysiology of generalized anxiety disorder, yet these abnormalities re